Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBenchmark Holdings Regulatory News (BMK)

  • There is currently no data for BMK

Genetics Breakthrough in Tilapia

11 Jul 2019 07:00

RNS Number : 1528F
Benchmark Holdings PLC
11 July 2019
 

 

Benchmark Holdings plc

 

("Benchmark" or the "Company")

Genetics breakthrough to increase resistance to Streptococcus iniae in tilapia

Addresses one of the biggest challenges in the world's second most farmed species

 

Benchmark, the aquaculture health, nutrition and genetics business, is pleased to announce a significant discovery to increase genetic resistance to Streptococcus iniae infections in tiliapia, one of the biggest challenges in the aquaculture industry.

 

Benchmark's team of geneticists have identified a significant quantitative trait locus (QTL), a small section of DNA, which is linked to increased levels of resistance to Streptococcus iniae. The Company has made a patent application in respect of this discovery.

 

The identified QTL will be used for commercial production of tilapia fry marking the first time that a significant QTL for disease resistance is used in commercial breeding of tilapia.

 

Tilapia is the world's second most farmed fish with 6.3 million tonnes of production in 2018 (estimated commercial value of ÂŁ6.6 bn) and is growing at c. 5% CAGR (2017 - 2022) according to the United Nations Food and Agriculture Organisation.

 

Following this discovery, Benchmark's tilapia broodstock are selected both for improved resistance to Streptococcus agalactiae using genomic selection, and to Streptococcus iniae using the identified QTL in marker-assisted selection.

 

Malcolm Pye, CEO Benchmark commented:

 

"This is a major step forward for the tilapia industry. It is the result of Benchmark's many years of investment and commitment to bringing state-of-the-art breeding technology to this important farmed species.

 

"We believe that this breakthrough will allow the industry to expand production of this cost effective, high-quality, protein source to meet global demand for protein. We have seen first hand how devastating Streptococcus is to the industry and with the introduction of this new technology we can drive improvements in sustainability and profitability for our customers."

 

 

- ENDS -

 

Enquiries

 

Benchmark Holdings plc

Tel: 020 3915 1236

Malcolm Pye, CEO

 

Mark Plampin, CFO

 

Ivonne Cantu, Investor Relations

 

 

 

 

 

Numis (Broker and NOMAD)

Tel: 020 7260 1000

James Black, Freddie Barnfield, Freddie Naylor-Leyland

 

 

 

MHP Communications

Tel: 020 3128 8226

Katie Hunt / Reg Hoare / Alistair de Kare-Silver benchmark@mphc.com

 

 

 

- ENDS -

 

About Benchmark Benchmark's mission is to enable food producers to improve their sustainability and profitability.

We bring together biology and technology, to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), sea lice treatments, training and data management tools. Find out more at www.benchmarkplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRARMMFTMBIBBBL
Date   Source Headline
18th Aug 20257:00 amRNSCancellation - BENCHMARK HOLDINGS PLC
18th Aug 20257:00 amRNSCancellation of Admissions to Trading
15th Aug 20257:00 amRNSLast day of trading
8th Aug 20251:06 pmRNSUpdate on the cancellation of trading of shares
31st Jul 20257:00 amRNSTotal Voting Rights
25th Jul 20255:37 pmRNSResult of Tender Offer - Replacement
25th Jul 20257:00 amRNSResult of Tender Offer
21st Jul 202512:00 pmRNSBoard and Management Changes
14th Jul 20253:10 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
10th Jul 20253:10 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
10th Jul 20257:00 amRNSForm 8.3 - Benchmark Holdings PLC
1st Jul 20257:00 amRNSUpdate on Conditions, Tender Offer and Timetable
30th Jun 20257:00 amRNSTotal Voting Rights
18th Jun 20254:30 pmRNSResult of GM
12th Jun 20253:01 pmRNSForm 8.3 - BENCHMARK HOLDINGS
12th Jun 20257:00 amRNSInterim Results
11th Jun 202512:20 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
10th Jun 20259:06 amRNSForm 8.3 - Benchmark Holdings Plc
6th Jun 20255:48 pmRNSForm 8.3 - Benchmark Holdings
6th Jun 20251:23 pmRNSChange of time: Retail Investor Webcast
6th Jun 20251:07 pmRNSForm 8.3 - Benchmark Holdings PLC
5th Jun 20252:05 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
4th Jun 20253:12 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
3rd Jun 20252:52 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
3rd Jun 20252:23 pmRNSForm 8.3 - Benchmark Holdings Plc
3rd Jun 202512:48 pmRNSHolding(s) in Company
2nd Jun 20254:15 pmRNSForm 8.3 - Benchmark Holdings Plc
2nd Jun 20254:01 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
2nd Jun 20254:00 pmRNSRule 2.9 Announcement and Total Voting Rights
2nd Jun 20251:00 pmRNSForm 8 (OPD) - Benchmark Holdings plc
2nd Jun 20251:00 pmRNSForm 8 (OPD) - Benchmark Holdings plc
30th May 202512:15 pmRNSForm 8.3 - Benchmark Holdings Plc
30th May 20258:45 amRNSForm 8.3 - BENCHMARK HOLDINGS PLC
28th May 202512:38 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
28th May 202511:06 amRNSForm 8.3 - BENCHMARK HOLDINGS PLC
28th May 202510:49 amRNSForm 8.3 - Benchmark Holdings plc
28th May 20259:10 amGNWForm 8.3 - [BENCHMARK HOLDINGS PLC - Opening Disclosure - 23 05 2025] - (CGAML)
27th May 20253:53 pmRNSNotice of Interim Results
27th May 20252:21 pmRNSForm 8.3 - Benchmark Holdings Plc
27th May 20251:46 pmRNSForm 8.3 - BENCHMARK HOLDINGS PLC
23rd May 20257:12 amRNSUpdate on Return of Capital and Proposed Delisting
30th Apr 20259:30 amRNSTotal Voting Rights
16th Apr 202512:00 pmRNSUpdate on Strategy and Return of Capital
15th Apr 20259:30 amRNSCompletion of Bond Redemption
1st Apr 20257:00 amRNSNotice of exercise of call option, bond redemption
31st Mar 20253:45 pmRNSCompletion of Disposal of the Genetics Business
31st Mar 20257:00 amRNSTotal Voting Rights
21st Mar 20257:00 amRNSBlock Listing Six Monthly Return
11th Mar 20253:30 pmRNSResult of AGM
28th Feb 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.